Reactive oxygen species (ROS) generated during Alzheimer's disease (AD) pathogenesis through multiple sources are implicated in synaptic pathology observed in the disease. We have previously shown F-actin disassembly in dendritic spines in early AD (34). The actin cytoskeleton can be oxidatively modified resulting in altered F-actin dynamics. Therefore, we investigated whether disruption of redox signaling could contribute to actin network disassembly and downstream effects in the amyloid precursor protein/presenilin-1 double transgenic (APP/PS1) mouse model of AD.
Results:
Synaptosomal preparations from 1-month-old APP/PS1 mice showed an increase in ROS levels, coupled with a decrease in the reduced form of F-actin and increase in glutathionylated synaptosomal actin. Furthermore, synaptic glutaredoxin 1 (Grx1) and thioredoxin levels were found to be lowered. Overexpressing Grx1 in the brains of these mice not only reversed F-actin loss seen in APP/PS1 mice but also restored memory recall after contextual fear conditioning. F-actin levels and F-actin nanoarchitecture in spines were also stabilized by Grx1 overexpression in APP/PS1 primary cortical neurons, indicating that glutathionylation of F-actin is a critical event in early pathogenesis of AD, which leads to spine loss.
Innovation:
Loss of thiol/disulfide oxidoreductases in the synapse along with increase in ROS can render F-actin nanoarchitecture susceptible to oxidative modifications in AD.
Conclusions:
Our findings provide novel evidence that altered redox signaling in the form of S-glutathionylation and reduced Grx1 levels can lead to synaptic dysfunction during AD pathogenesis by directly disrupting the F-actin nanoarchitecture in spines. Increasing Grx1 levels is a potential target for novel disease-modifying therapies for AD.
Get full access to this article
View all access options for this article.
References
1.
AhmadF, SinghK, DasD, GowaikarR, ShawE, RamachandranA, RupanagudiKV, KommaddiRP, BennettDA, and RavindranathV. Reactive oxygen species-mediated loss of synaptic Akt1 signaling leads to deficient activity-dependent protein translation early in Alzheimer's disease. Antioxid Redox Signal, 27: 1269–1280, 2017.
2.
AksenovMY, AksenovaMV, ButterfieldDA, GeddesJW, and MarkesberyWR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience, 103: 373–383, 2001.
3.
AksenovMY and MarkesberyWR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett, 302: 141–145, 2001.
4.
AkterinS, CowburnRF, Miranda-VizueteA, JiménezA, BogdanovicN, WinbladB, and Cedazo-MinguezA. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ, 13: 1454–1465, 2006.
5.
AnsariMA and ScheffSW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol, 69: 155–167, 2010.
6.
ArodinL, LamparterH, KarlssonH, NennesmoI, BjörnstedtM, SchröderJ, and FernandesAP. Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer's disease. J Alzheimers Dis, 39: 787–797, 2014.
7.
BamburgJR and BernsteinBW. Actin dynamics and cofilin-actin rods in Alzheimer disease. Cytoskeleton (Hoboken), 73: 477–497, 2016.
8.
BertlingE, EnglundJ, MinkevicieneR, KoskinenM, SegerstråleM, CastrénE, TairaT, and HotulainenP. Actin tyrosine-53-phosphorylation in neuronal maturation and synaptic plasticity. J Neurosci, 36: 5299–5313, 2016.
9.
ButterfieldDA and Boyd-KimballD. Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer's disease. J Alzheimers Dis, 62: 1345–1367, 2018.
10.
ButterfieldDA, Di DomenicoF, and BaroneE. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta, 1842: 1693–1706, 2014.
11.
ButterfieldDA, Di DomenicoF, SwomleyAM, HeadE, and PerluigiM. Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain. Biochem J, 463: 177–189, 2014.
12.
ButterfieldDA and LauderbackCM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med, 32: 1050–1060, 2002.
CheignonC, TomasM, Bonnefont-RousselotD, FallerP, HureauC, and CollinF. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol, 14: 450–464, 2018.
15.
Dalle-DonneI, GiustariniD, RossiR, ColomboR, and MilzaniA. Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med, 34: 23–32, 2003.
16.
Di DomenicoF, BaroneE, PerluigiM, and ButterfieldDA. The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics. Antioxid Redox Signal, 26: 364–387, 2017.
17.
Domenico FDi, CeniniG, SultanaR, PerluigiM, UbertiD, MemoM, and ButterfieldDA. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis. Neurochem Res, 34: 727–733, 2009.
18.
EfimovaN, KorobovaF, StankewichMC, MoberlyAH, StolzDB, WangJ, KashinaA, MaM, and SvitkinaT. βIII spectrin is necessary for formation of the constricted neck of dendritic spines and regulation of synaptic activity in neurons. J Neurosci, 37: 6442–6459, 2017.
19.
FarahME and AmbergDC. Conserved actin cysteine residues are oxidative stress sensors that can regulate cell death in yeast. Mol Biol Cell, 18: 1359–1365, 2007.
20.
FarahME, SirotkinV, HaarerB, KakhniashviliD, and AmbergDC. Diverse protective roles of the actin cytoskeleton during oxidative stress. Cytoskeleton, 68: 340–354, 2011.
21.
FedorovaM, KulevaN, and HoffmannR. Reversible and irreversible modifications of skeletal muscle proteins in a rat model of acute oxidative stress. Biochim Biophys Acta, 1792: 1185–1193, 2009.
22.
García-OrtizA, Martín-CofrecesNB, IbizaS, OrtegaÁ, Izquierdo-ÁlvarezA, TrulloA, VictorVM, CalvoE, SotB, Martínez-RuizA, VázquezJ, Sánchez-MadridF, and SerradorJM. eNOS S-nitrosylates β-actin on Cys374 and regulates PKC-θ at the immune synapse by impairing actin binding to profilin-1. PLoS Biol, 15: e2000653, 2017.
23.
GrimmD, KayMA, and KleinschmidtJA. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther, 7: 839–850, 2003.
24.
Guillozet-BongaartsAL, Garcia-SierraF, and BerryRW. Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta, 1739: 216–223, 2005.
25.
HanBH, ZhouM-L, JohnsonAW, SinghI, LiaoF, VellimanaAK, NelsonJW, MilnerE, CirritoJR, BasakJ, YooM, DietrichHH, HoltzmanDM, and ZipfelGJ. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice. Proc Natl Acad Sci U S A, 112: E881–E890, 2015.
26.
HerediaL, HelgueraP, de OlmosS, KedikianG, Solá VigoF, LaFerlaF, StaufenbielM, de OlmosJ, BusciglioJ, CáceresA, and LorenzoA. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. J Neurosci, 26: 6533–6542, 2006.
27.
HermsJ and DorostkarMM. Dendritic spine pathology in neurodegenerative diseases. Annu Rev Pathol, 11: 221–250, 2016.
28.
HoY-S, XiongY, HoDS, GaoJ, ChuaBHL, PaiH, and MieyalJJ. Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia. Free Radic Biol Med, 43: 1299–1312, 2007.
29.
HotulainenP and HoogenraadCC. Actin in dendritic spines: connecting dynamics to function. J Cell Biol, 189: 619–629, 2010.
30.
HuangW, ZhuPJ, ZhangS, ZhouH, StoicaL, GalianoM, KrnjevićK, RomanG, and Costa-MattioliM. mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat Neurosci, 16: 441–448, 2013.
31.
HungR-J, PakCW, and TermanJR. Direct redox regulation of F-actin assembly and disassembly by mical. Science, 334: 1710–1713, 2011.
32.
HungR-J, SpaethCS, YesilyurtHG, and TermanJR. SelR reverses mical-mediated oxidation of actin to regulate F-actin dynamics. Nat Cell Biol, 15: 1445–1454, 2013.
33.
JohnsonWM, Wilson-DelfosseAL, ChenSG, and MieyalJJ. The roles of redox enzymes in Parkinson's disease: focus on glutaredoxin. Ther targets Neurol Dis, 2: e790, 2015.
34.
KommaddiRP, DasD, KarunakaranS, NanguneriS, BapatD, RayA, ShawE, BennettDA, NairD, and RavindranathV. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci, 38: 1085–1099, 2018.
35.
LassingI, SchmitzbergerF, BjörnstedtM, HolmgrenA, NordlundP, SchuttCE, and LindbergU. Molecular and structural basis for redox regulation of β-actin. J Mol Biol, 370: 331–348, 2007.
36.
LiS, HongS, ShepardsonNE, WalshDM, ShankarGM, and SelkoeD. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron, 62: 788–801, 2009.
37.
MartinsRN, VillemagneV, SohrabiHR, ChatterjeeP, ShahTM, VerdileG, FraserP, TaddeiK, GuptaVB, Rainey-SmithSR, HoneE, PedriniS, LimWL, MartinsI, FrostS, GuptaS, O'BryantS, RembachA, AmesD, EllisK, FullerSJ, BrownB, GardenerSL, FernandoB, BharadwajP, BurnhamS, LawsSM, BarronAM, GoozeeK, WahjoepramonoEJ, AsihPR, DoeckeJD, SalvadoO, BushAI, RoweCC, GandySE, and MastersCL. Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies. J Alzheimers Dis, 62: 965–992, 2018.
38.
McBeanGJ, AslanM, GriffithsHR, and TorrãoRC. Thiol redox homeostasis in neurodegenerative disease. Redox Biol, 5: 186–194, 2015.
39.
Mendoza-NaranjoA, Contreras-VallejosE, HenriquezDR, OtthC, BamburgJR, MaccioniRB, and Gonzalez-BillaultC. Fibrillar amyloid-β1–42 modifies actin organization affecting the cofilin phosphorylation state: a role for Rac1/cdc42 effector proteins and the slingshot phosphatase. J Alzheimers Dis, 29: 63–77, 2012.
40.
NanguneriS, PramodRT, EfimovaN, DasD, JoseM, SvitkinaT, and NairD. Characterization of nanoscale organization of F-actin in morphologically distinct dendritic spines in vitro using supervised learning. eNeuro, 6: 0425-18.2019, 2019.
41.
NewmanSF, SultanaR, PerluigiM, CocciaR, CaiJ, PierceWM, KleinJB, TurnerDM, and ButterfieldDA. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res, 85: 1506–1514, 2007.
42.
OuyangW, AristovA, LelekM, HaoX, and ZimmerC. Deep learning massively accelerates super-resolution localization microscopy. Nat Biotechnol, 36: 460–468, 2018.
43.
PaiH V, StarkeDW, LesnefskyEJ, HoppelCL, and MieyalJJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria?. Antioxid Redox Signal, 9: 2027–2033, 2007.
44.
RayA, SehgalN, KarunakaranS, RangarajanG, and RavindranathV. MPTP activates ASK1–p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model. Free Radic Biol Med, 87: 312–325, 2015.
45.
ResendeR, MoreiraPI, ProençaT, DeshpandeA, BusciglioJ, PereiraC, and OliveiraCR. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med, 44: 2051–2057, 2008.
46.
Rodriguez-RochaH, Garcia GarciaA, Zavala-FloresL, LiS, MadayiputhiyaN, and FrancoR. Glutaredoxin1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease. Antioxid Redox Signal, 17: 1676–1693, 2012.
47.
RohrU-P, HeydF, NeukirchenJ, WulfM-A, QueitschI, Kroener-LuxG, SteidlU, FenkR, HaasR, and KronenwettR. Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles. J Virol Methods, 127: 40–45, 2005.
48.
RubensteinPA and WenK-K. NATure of actin amino-terminal acetylation. Proc Natl Acad Sci U S A, 115: 4314–4316, 2018.
49.
SabensEA, DistlerAM, and MieyalJJ. Levodopa deactivates enzymes that regulate thiol−disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease. Biochemistry, 49: 2715–2724, 2010.
50.
SaeedU, DurgadossL, ValliRK, JoshiDC, JoshiPG, and RavindranathV. Knockdown of cytosolic glutaredoxin1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases. PLoS One, 3: e2459, 2008.
51.
SaeedU, RayA, ValliRK, KumarAMR, and RavindranathV. DJ-1 loss by glutaredoxin but not glutathione depletion triggers daxx translocation and cell death. Antioxid Redox Signal, 13: 127–144, 2010.
SheltonMD, ChockPB, and MieyalJJ. Glutaredoxin: role in reversible protein s-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal, 7: 348–366, 2005.
54.
Spires-JonesTL, Meyer-LuehmannM, OsetekJD, JonesPB, SternEA, BacskaiBJ, and HymanBT. Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am J Pathol, 171: 1304–1311, 2007.
55.
SpiresTL, Meyer-LuehmannM, SternEA, McLeanPJ, SkochJ, NguyenPT, BacskaiBJ, and HymanBT. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci, 25: 7278–7287, 2005.
56.
StapperZA and JahnTR. Changes in glutathione redox potential are linked to Aβ42-induced neurotoxicity. Cell Rep, 24: 1696–1703, 2018.
57.
StegerC. An unbiased detector of curvilinear structures carsten steger. IEEE Trans Pattern Anal Mach Intell, 20: 113–125, 1998.
58.
StojkovD, AminiP, ObersonK, SokollikC, DuppenthalerA, SimonH-U, and YousefiS. ROS and glutathionylation balance cytoskeletal dynamics in neutrophil extracellular trap formation. J Cell Biol, 216: 4073–4090, 2017.
59.
SultanaR, PerluigiM, and ButterfieldDA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med, 62: 157–169, 2013.
60.
SultanaR, ReedT, PerluigiM, CocciaR, PierceWM, and ButterfieldDA. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study. J Cell Mol Med, 11: 839–851, 2007.
61.
TermanJR and KashinaA. Post-translational modification and regulation of actin. Curr Opin Cell Biol, 25: 30–38, 2013.
62.
TönniesE and TrushinaE. Oxidative stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimers Dis, 57: 1105–1121, 2017.
63.
TowneC and AebischerP. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi. Methods Mol Biol, 555: 87–108, 2009.
64.
TowneC, RaoulC, SchneiderBL, and AebischerP. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol Ther, 16: 1018–1025, 2008.
65.
TsaiJ, GrutzendlerJ, DuffK, and GanW-B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci, 7: 1181–1183, 2004.
66.
WangH, MaJ, TanY, WangZ, ShengC, ChenS, and DingJ. Amyloid-β1–42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells. J Alzheimers Dis, 21: 597–610, 2010.
67.
WangZ-X, TanL, LiuJ, and YuJ-T. The essential role of soluble Aβ oligomers in alzheimer's disease. Mol Neurobiol, 53: 1905–1924, 2016.
68.
WilsonC and González-BillaultC. Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking. Front Cell Neurosci, 9: 381, 2015.
69.
XuK, ZhongG, and ZhuangX. Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science, 339: 452–456, 2013.
70.
ZhangC, RodriguezC, SpauldingJ, AwTY, and FengJ. Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease. J Alzheimers Dis, 28: 655–666, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
